A 50-year-old with chest pain and suspected NSTEMI receives UFH and ticagrelor. He becomes hypotensive with massive hematemesis; endoscopy reveals active bleeding. After endoscopic hemostasis, what antithrombotic step aligns with bleeding management guidance?